Opioids
New Front Emerges in Fight Against Synthetic Opioids
The U.S. opioid crisis has already claimed hundreds of thousands of lives, with fentanyl standing out as one of the deadliest substances. Now the leading cause of death among Americans aged 18 to 44, fentanyl has become synonymous with overdose…
Cencora Directors Settle Opioid Oversight Case for $111M
Last Updated: October 3, 2025
Cencora has agreed to pay $111.3 million to settle a shareholder lawsuit accusing the company’s directors of failing to prevent the unlawful distribution of…
FDA Adds New Warnings on Long-Term Opioid Risks
Federal regulators have raised concerns that many opioid medications were approved for prolonged use without sufficient clinical evidence confirming their safety.
…
Suboxone MDL Judge Orders Pharmacies to Explain Record Delays
The U.S. District Judge overseeing all Suboxone tooth decay lawsuits has ordered a number of pharmacies to “show cause” why they should not be held in contempt or face sanctions for failing to provide prescription records requested by plaintiffs…
FDA Moves to Restrict Dangerous 7-OH Opioid Products
In a significant move to combat the ongoing opioid crisis, the U.S. Food and Drug Administration (FDA) has recommended a scheduling action under the Controlled Substances Act (CSA) to regulate certain products containing 7-hydroxymitragynine (7-…
Indiana Secures Over $1.1B in Opioid Settlements Since 2021
Indiana is set to receive an additional $16.5 million as part of a nationwide opioid settlement involving several pharmaceutical manufacturers.
The announcement…
NC to Get $150M to Boost Opioid Treatment, Recovery
North Carolina will receive an additional $150 million from Purdue Pharma and the Sackler family as part of a national $7.4 billion settlement related to the opioid…
SRI Gets FDA OK for High-Dose Naloxone Trial
SRI has received authorization from the U.S. Food and Drug Administration (FDA) to begin Phase 1 clinical trials of a new, high-dose injectable naloxone formulation.
The approval was granted under an Investigational New Drug (IND)…
Spokane County to Get $5M in New Opioid Settlement
Jurisdictions within Spokane County are set to receive nearly $4.7 million as part of a sweeping $7.4 billion nationwide settlement with Purdue Pharma and its owners, the Sackler family.
The agreement addresses the company’s role in fueling…
Purdue, Sacklers Agree to New $7.4B Opioid Settlement
All 50 U.S. states, along with the District of Columbia and U.S. territories, have agreed to a $7.4 billion settlement with Purdue Pharma, the manufacturer of OxyContin.
This deal addresses allegations that the company’s aggressive and…